Factors Influencing the Evolution of Pulmonary Hypertension in Previously Healthy Subjects Recovering from a SARS-CoV-2 Infection
Cristina Tudoran, Mariana Tudoran, Voichița Elena Lăzureanu, Adelina Raluca Marinescu, Talida Georgiana Cut, Cristian Oancea, S. Pescariu, Gheorghe
Abstract
Background: While the COVID-19 pandemic has been persisting for almost 2 years, more and more people are diagnosed with residual complications such as pulmonary hypertension (PH) and right ventricular dysfunction (RVD). This study aims to evaluate the course of PH and borderline PH (BPH) at 3 and 6 months after the acute COVID-19 infection and investigate if there are differences regarding its evolution between the patients from the first three waves of this disease.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineVirologyPulmonary hypertensionIntensive care medicineInternal medicineInfectious disease (medical specialty)DiseaseOutbreakLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationLong-Term Effects of COVID-19